Ohio Zantac Lawyer

If you have taken the widely-used heartburn drug Zantac, it’s important to understand the possible dangers of this drug, which has come under the U.S. Food and Drug Administration’s (FDA) microscope in recent months. The FDA has pulled Zantac and its generic equivalents from shelves, citing concerns of unsafe levels of the impurity nitrosodimethylamine (NDMA), which is believed to be related to the active ingredient in Zantac, ranitidine.  NDMA is a material known to cause cancer (probable carcinogen).  NDMA has been found in both finished drug product samples and active product ingredients (APIs).  All forms of ranitidine, including oral liquid/syrup, have been pulled off the market.

What is Zantac?

Zantac is a histamine-2 or H2 blocker, one of a group of medicines that reduced the amount of acid produced by the cells in the lining of the stomach.  H2 blockers are common treatments for heartburn, along with acid reflux and other stomach, throat, and gastrointestinal issues. Zantac has been on the market since the early 1980’s, and generic forms of ranitidine have been available since 1997.  These products are popular because they are fast-acting and effective.   If you have taken Zantac and have been diagnosed with any of the following cancers, you may have a legal claim against the manufacturers of these products:

  • Acute lymphoblastic leukemia (ALL)
  • Bladder Cancer
  • Brain Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer
  • Nasal/Throat Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Small Intestine Cancer
  • Stomach Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Uterine Cancer

Concerns about ranitidine were first raised by the FDA in September 2019, when the FDA issued a warning to health care providers and patients that the impurity NDMA had been discovered in ranitidine. A voluntary recall followed shortly thereafter, with the FDA removing all Zantac and generic ranitidine products from the market in April 2020.

Free Zantac Cancer Lawsuit Evaluation

Many lawsuits have already been filed against GlaxoSmithKline, the original maker of branded Zantac, and it is important to get involved in these lawsuits early, if possible.  GBM Law is actively reviewing and investigating Zantac lawsuits and legal actions.  If you would like a free consultation, we will review your case and evaluate legal action against the manufacturers of the drug, along with distributors and sellers. Your case will be handled on a contingency fee basis, which means there are zero out-of-pocket or up-front fees. We are only paid, if and when, we recover money for you.